rss
Br J Ophthalmol 87:173-176 doi:10.1136/bjo.87.2.173
  • Original Article
    • Clinical science

Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation

Table 1

Evolution of choroidal neovascularisation (CNV) diameter (μm) after treatment with photodynamic therapy

Group 1
D0 D3 D6 D9 D12
1890 1815 0 1792 0
2249 1821 0 0 0
743 0 0 0 0
1996 0 0 0 0
1007 0 998 1735 1768
1104 0 0 0 0
1782 1525 0 0 0
645 1851 2225 2179 0
2393 1251 0 0 1115
2147 1705 1512 1730 0
1740 1720 1703 1652 0
3523 2261 2165 0 0
1362 1324 1324 1085 1284
2850 2022 1734 1207 0
1229 1548 1077 1360 0
1564 1782 0 0 0
2781 2430 1943 2419 0
1335 580 1354 1152 825
Group 2
D0 D3 D6 D9 D12
D0 = CNV diameter before treatment; D3 = CNV diameter 3 months after the first treatment; D6 = CNV diameter 6 months after the first treatment; D9 = CNV diameter 9 months after the first treatment; D12 = CNV diameter 12 months after the first treatment.
2468 0 0 0 0
1513 2570 0 0 0
1128 0 1374 1174 1130
2849 2693 0 2579 2465
2987 947 2349 0 0
348 0 0 0 0
945 0 0 0 0
1520 1451 1576 1452 1257
814 933 1964 2059 0
1085 0 1097 0 0
1027 802 0 0 0
1450 2364 0 0 0
1982 2256 2570 2048 0

This Article

  1. Abstract
  2. Full text
  3. PDF

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.